Umoja Biopharma
PrivateLast Round
IPO
Apr 9, 2026
Est. Valuation
$420M
Total Funding Raised
$373M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Umoja Biopharma is a biotechnology company that develops in vivo immunotherapies to reprogram a patient's immune system to fight cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Umoja Biopharma Comparables
Compare Umoja Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CREATE Medicines | 83% | |
| AbbVie | 81% | |
| Sana Biotechnology | 79% |
Umoja Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Apr 9, 2026 | ||||
| Series C | Jan 14, 2025 | ||||
| Seed | Jan 9, 2024 | ||||
| Series B | Jun 15, 2021 | ||||
| Series A | Nov 18, 2020 | ||||
Seed | Nov 21, 2019 |
Umoja Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MPM Capital | Series B, Seed, Series C, Series A |
| SoftBank Investment Advisers | Series C, Series B |
| Temasek | Series B |
| DCVC Bio | Series B, Seed, Series A, Series C |
| Cormorant Asset Management | Series C, Series B |
| Psalion VC | Seed |
| Orange DAO | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2026
Completed an IPO round of funding.
- Apr 9, 2026
Opened a new cell/gene therapy GMP manufacturing facility in Louisville, CO.
Umoja Biopharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Umoja Biopharma's valuation, stock price, and market status.
Is Umoja Biopharma a public or private company?
Umoja Biopharma is a private company.
What is the current stock price of Umoja Biopharma?
Umoja Biopharma is a private company with no public stock price. No recent secondary market data is available.
How much is Umoja Biopharma worth (valuation)?
Umoja Biopharma's valuation is estimated at $800.0M based on funding round data.
Can I buy Umoja Biopharma stock?
Umoja Biopharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Umoja Biopharma's last funding round?
Umoja Biopharma's most recent funding round was ipo on January 14, 2025.
Who are the main investors in Umoja Biopharma?
Key investors in Umoja Biopharma include MPM Capital, SoftBank Investment Advisers, DCVC Bio, SoftBank Group, Qiming.
Will Umoja Biopharma IPO soon?
No public IPO plans have been announced for Umoja Biopharma.
How can I track Umoja Biopharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Umoja Biopharma's secondary market activity and sign up for updates.